FDA.reportPublic FDA data

RoxyBond 5 MG Oral Tablet

RxCUI
1944543
RxNorm name
RoxyBond 5 MG Oral Tablet
Display name
RoxyBond 5 MG Oral Tablet
Full name
RoxyBond 5 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RoxyBondOXYCODONE HYDROCHLORIDEProtega Pharmaceuticals Inc72398542-8e0a-47b2-afeb-9ca5a1f150832026-01-13Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1944543

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
72398542-8e0a-47b2-afeb-9ca5a1f15083RoxyBond 5 MG Oral Tablet [PSN] · Abuse-Deterrent oxycodone hydrochloride 5 MG Oral Tablet [Roxybond] [SBD] · RoxyBond 5 MG Oral Tablet [SY]311These highlights do not include all the information needed to use ROXYBOND™ safely and effectively. See full prescribing information for ROXYBOND. ROXYBOND (oxycodone hydrochloride) tablets, for oral use, CII Initial U.S. Approval: 195020260113